Related Experiment Videos
A putative growth factor in extract from uterine cancers
K Matsunami1, A Imai, T Tamaya
1Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan.
Research Communications in Chemical Pathology and Pharmacology
|December 1, 1989
Summary
Uterine cancer extracts promote endometrial fibroblast proliferation, suggesting a novel growth factor. This study identifies a potential mechanism in uterine tumor development and provides evidence for a secreted peptide.
Area of Science:
- Gynecologic Oncology
- Cell Biology
- Molecular Endocrinology
Background:
- Uterine cancers, including cervical and corpus cancers, are significant health concerns.
- The proliferation of endometrial fibroblasts plays a role in uterine tissue dynamics.
- Understanding the molecular mechanisms driving cancer growth is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the presence of growth-promoting activity in uterine cancer extracts.
- To characterize the nature of this activity and its potential signaling pathways.
- To determine if malignant uterine tumors secrete a novel growth factor-like substance.
Main Methods:
- Preparation of extracts from uterine cervical and corpus cancers, benign tumors, and intact tissues.
- Assessing the effect of extracts on the proliferation of cultured human endometrial fibroblasts.
- Measuring [3H]thymidine incorporation to quantify DNA synthesis.
- Evaluating the heat lability and lipid solubility of the growth-promoting activity.
- Investigating the involvement of phosphoinositide turnover and binding of known growth factors.
Main Results:
- Extracts from uterine cervical and corpus cancers exhibited significant growth-promoting activity on endometrial fibroblasts.
- This activity increased [3H]thymidine incorporation in a dose-dependent manner.
- The activity was heat-labile and not dependent on lipid-soluble fractions, indicating a proteinaceous nature.
- The cancer extracts did not stimulate phosphoinositide turnover or inhibit the binding of known growth factors.
Conclusions:
- Malignant uterine tumors produce and secrete a substance with growth-promoting activity on endometrial fibroblasts.
- This putative growth factor-like peptide may activate fibroblast proliferation via signaling pathways distinct from phosphoinositide turnover.
- This finding provides the first direct evidence for a novel peptide secreted by malignant uterine tumors that influences fibroblast proliferation.